ZR2 Bioenergy Limited
ZR2 Bioenergy Limited Fundamental Analysis
ZR2 Bioenergy Limited (ZR2.BO) shows weak financial fundamentals with a PE ratio of 584.52, profit margin of 2.06%, and ROE of 0.05%. The company generates $0.0B in annual revenue with N/A year-over-year growth of N/A.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 56.3/100 based on profitability, valuation, growth, and balance sheet metrics. The C grade reflects average fundamentals, with notable risks in certain areas.
Fundamental Health Score
We analyze ZR2.BO's fundamental strength across five key dimensions:
Efficiency Score
WeakZR2.BO struggles to generate sufficient returns from assets.
Valuation Score
WeakZR2.BO trades at a premium to fair value.
Growth Score
ModerateZR2.BO shows steady but slowing expansion.
Financial Health Score
ExcellentZR2.BO maintains a strong and stable balance sheet.
Profitability Score
WeakZR2.BO struggles to sustain strong margins.
Key Financial Metrics
Is ZR2.BO Expensive or Cheap?
P/E Ratio
ZR2.BO trades at 584.52 times earnings. This suggests a premium valuation.
PEG Ratio
When adjusting for growth, ZR2.BO's PEG of 4.79 indicates potential overvaluation.
Price to Book
The market values ZR2 Bioenergy Limited at 0.28 times its book value. This may indicate undervaluation.
EV/EBITDA
Enterprise value stands at 266.60 times EBITDA. This signals the market has high growth expectations.
How Well Does ZR2.BO Make Money?
Net Profit Margin
For every $100 in sales, ZR2 Bioenergy Limited keeps $2.06 as profit after all expenses.
Operating Margin
Core operations generate -8.19 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $0.05 in profit for every $100 of shareholder equity.
ROA
ZR2 Bioenergy Limited generates $0.05 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
ZR2 Bioenergy Limited generates limited operating cash flow of $0.00, signaling weaker underlying cash strength.
Free Cash Flow
ZR2 Bioenergy Limited generates weak or negative free cash flow of $0.00, restricting financial flexibility.
FCF Per Share
Each share generates $0.00 in free cash annually.
FCF Yield
ZR2.BO converts 0.00% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
584.52
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
4.79
vs 25 benchmark
P/B Ratio
Price to book value ratio
0.28
vs 25 benchmark
P/S Ratio
Price to sales ratio
1206.63
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.00
vs 25 benchmark
Current Ratio
Current assets to current liabilities
126.65
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.00
vs 25 benchmark
ROA
Return on assets percentage
0.00
vs 25 benchmark
ROCE
Return on capital employed
-0.00
vs 25 benchmark
How ZR2.BO Stacks Against Its Sector Peers
| Metric | ZR2.BO Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 584.52 | 23.91 | Worse (Expensive) |
| ROE | 0.05% | 887.00% | Weak |
| Net Margin | 205.92% | -114589.00% (disorted) | Strong |
| Debt/Equity | 0.00 | 0.55 | Strong (Low Leverage) |
| Current Ratio | 126.65 | 5.05 | Strong Liquidity |
| ROA | 0.05% | -6361.00% (disorted) | Weak |
ZR2.BO outperforms its industry in 3 out of 6 key metrics, particularly excelling in Net Margin, but lagging in P/E Ratio.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews ZR2 Bioenergy Limited's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
N/A
Industry Style: Cyclical, Commodity, Value
EPS CAGR
N/A
Industry Style: Cyclical, Commodity, Value
FCF CAGR
N/A
Industry Style: Cyclical, Commodity, Value